Similarly, adiponectin generally predicts steatosis grade and the severity of NAFLD, although to what extent this is a direct effect or related to the presence of more severe insulin resistance or obesity remains to be addressed [50]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.